HomeCompareAOTS vs MRK

AOTS vs MRK: Dividend Comparison 2026

AOTS yields 9.52% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AOTS wins by $6.8K in total portfolio value
10 years
AOTS
AOTS
● Live price
9.52%
Share price
$21.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.6K
Annual income
$1,734.44
Full AOTS calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — AOTS vs MRK

📍 AOTS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAOTSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AOTS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AOTS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AOTS
Annual income on $10K today (after 15% tax)
$809.52/yr
After 10yr DRIP, annual income (after tax)
$1,474.27/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, AOTS beats the other by $666.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AOTS + MRK for your $10,000?

AOTS: 50%MRK: 50%
100% MRK50/50100% AOTS
Portfolio after 10yr
$34.2K
Annual income
$1,342.37/yr
Blended yield
3.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AOTS
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AOTS buys
0
MRK buys
0
No recent congressional trades found for AOTS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAOTSMRK
Forward yield9.52%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$37.6K$30.7K
Annual income after 10y$1,734.44$950.29
Total dividends collected$13.4K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AOTS vs MRK ($10,000, DRIP)

YearAOTS PortfolioAOTS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,652$952.38$11,192$351.54+$460.00AOTS
2$13,505$1,037.15$12,524$392.70+$981.00AOTS
3$15,574$1,123.43$14,015$438.65+$1.6KAOTS
4$17,875$1,210.76$15,682$489.96+$2.2KAOTS
5$20,425$1,298.73$17,547$547.23+$2.9KAOTS
6$23,242$1,386.92$19,632$611.16+$3.6KAOTS
7$26,343$1,474.94$21,963$682.53+$4.4KAOTS
8$29,750$1,562.41$24,571$762.18+$5.2KAOTS
9$33,481$1,649.02$27,486$851.08+$6.0KAOTS
10$37,560$1,734.44$30,745$950.29+$6.8KAOTS

AOTS vs MRK: Complete Analysis 2026

AOTSStock

AOTS tracks an index of companies classified as software-driven enterprises, whose core business relies on software platforms and generates at least 20% of revenue from software-driven activities (cloud infrastructure, enterprise software, development tools, analytics/AI, middleware, industry solutions). Companies must have a positive Earnings to Price ratio to qualify. Selection is based on the average rank of a factor score (cost of goods sold/revenue, earnings/price, return on invested capital) and market cap, with the top 50 ranked firms and a 10-company buffer for incumbents. Weighting favors companies with over 50% software revenue, while those below are capped at 20%. Weights are float-adjusted, max 7.5%, min 0.5%, with over-5% weights keeping below 45% in total. The index is reconstituted and rebalanced on the third Friday of March, June, September, and December.

Full AOTS Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this AOTS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AOTS vs SCHDAOTS vs JEPIAOTS vs OAOTS vs KOAOTS vs MAINAOTS vs JNJAOTS vs ABBVAOTS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.